Carlos Plaza

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

Rafael Álvarez, Mónica Musteanu, Elena García-García et al. · British Journal of Cancer · 2013 · 289 citations · Full text

Level of <i>HER2</i> Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

Carlos Gómez-Martín, Carlos Plaza, Roberto Pazo-Cid et al. · Journal of Clinical Oncology · 2013 · 195 citations · Full text

SPARC Expression Did Not Predict Efficacy of <i>nab</i> -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

Manuel Hidalgo, Carlos Plaza, Mónica Musteanu et al. · Clinical Cancer Research · 2015 · 127 citations · Full text

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

Bárbara Angulo, Esther Conde, Ana Suárez‐Gauthier et al. · PLoS ONE · 2012 · 106 citations · Full text

Cancer Pathology, Genetics, Pathology +24

A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma

Benedetto Ielpo, Riccardo Caruso, Hipólito Durán et al. · Surgical Oncology · 2017 · 74 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +9